Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C
2021 ◽
Vol 27
(10)
◽
pp. 1388-1402
Keyword(s):
2018 ◽
Vol 12
(5)
◽
pp. 346-352
◽
2019 ◽
Vol 71
(6)
◽
pp. 1076-1085
◽
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 10
(10)
◽
pp. 572-574
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 58
(12)
◽
pp. 1154
◽
Keyword(s):